603716 塞力医疗
2026/06 - 中期2025/122024/122023/122022/12

盈利能力分析
净资产收益率 ROE (%)-4.697-22.063-19.508-12.135-10.371
总资产报酬率 ROA (%)-2.820-8.949-6.780-4.344-3.726
投入资产回报率 ROIC (%)-3.414-12.364-9.860-6.032-4.957

边际利润分析
销售毛利率 (%)21.23322.31618.32919.57519.863
营业利润率 (%)-16.935-13.658-7.831-8.989-6.433
息税前利润/营业总收入 (%)-15.311-11.289-5.148-5.963-4.477
净利润/营业总收入 (%)-15.027-18.705-10.680-7.815-8.241

收益指标分析
经营活动净收益/利润总额(%)88.24659.83954.39633.2137.248
价值变动净收益/利润总额(%)2.791-3.72343.9771.2353.104
营业外收支净额/利润总额(%)-0.7683.4614.3856.32822.528

偿债能力分析
流动比率 (X)1.8961.4191.5221.7161.607
速动比率 (X)1.5461.1631.2841.4711.378
资产负债率 (%)35.49149.81966.00660.65962.188
带息债务/全部投入资本 (%)18.88432.39049.08944.91248.892
股东权益/带息债务 (%)421.574203.95398.970116.15997.700
股东权益/负债合计 (%)193.483105.20450.01559.73656.971
利息保障倍数 (X)-10.243-3.950-1.693-1.641-1.170

营运能力分析
应收账款周转天数 (天)345.653338.092279.815295.469274.368
存货周转天数 (天)137.566118.23481.28085.05086.043